LLY - Stock held $720 support next level at $760LLY - Stock back to bouncing off $720 support level on the weekly time frame. Needs to break and hold $760 resistance level for a move towards $800 . Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial. calls above $760 look good for a move towards $800
Key facts today
HSBC has revised its price target for Eli Lilly and Company to $675 from $700, while keeping a 'Reduce' rating on the stock.
4,084.16
0.03 BRL
57.09 B BRL
242.82 B BRL
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
BRLILYBDR006
FIGI
BBG002QBHFC7
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Can Lilly Redefine Weight Loss Market Leadership?Eli Lilly is rapidly emerging as a dominant force in the burgeoning weight loss drug market, presenting a significant challenge to incumbent leader Novo Nordisk. Lilly has demonstrated remarkable commercial success despite its key therapy, Zepbound (tirzepatide), entering the market well after Novo
Eli Lilly (LLY) Shares Fall Over 15% in MayEli Lilly (LLY) Shares Fall Over 15% in May
The share price of Eli Lilly and Company (LLY), the world’s largest pharmaceutical company, has seen a sharp shift in market sentiment:
→ From its April low to high, LLY shares rose by over 30%;
→ However, since the start of May, the LLY stock price has
LLY bullish reversal confirmed.. BUY BUY BUYLLY bully reversal is absolutely confirmed
We have the following confirmations
1) closed above 20 day EMA
2) closed above 50 day EMA
3) closed above 200 day EMA
4) RSI above 60
wait till another candle closes above 200 day EMA
Buy at 866
Stop loss @ 790
TP @ 964
LLY possible buy trend This chart highlights a recent price breakout followed by a pullback into consolidation.
Key indicators in play:
✅ EMA 9/20/56: Price is currently trading below all EMAs, showing fading momentum. The EMAs are curling down, suggesting short-term weakness or cooling after a strong move.
🟣 SMA 50 & 2
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
US532457AM0
ELI LILLY 2025Yield to maturity
12.32%
Maturity date
Jun 1, 2025
LLYC
ELI LILLY 15/25Yield to maturity
9.77%
Maturity date
Jun 1, 2025
XS238628644
ELI LILLY 21/43Yield to maturity
7.72%
Maturity date
Sep 14, 2043
US532457BY3
ELI LILLY 20/50Yield to maturity
7.45%
Maturity date
May 15, 2050
US532457BZ0
ELI LILLY 20/60Yield to maturity
7.35%
Maturity date
Sep 15, 2060
US532457BT4
ELI LILLY 19/49Yield to maturity
6.37%
Maturity date
Mar 15, 2049
US532457BU1
ELI LILLY 19/59Yield to maturity
6.35%
Maturity date
Mar 15, 2059
LLY4492882
Eli Lilly and Company 3.95% 15-MAY-2047Yield to maturity
6.31%
Maturity date
May 15, 2047
US532457BS6
ELI LILLY 19/39Yield to maturity
6.17%
Maturity date
Mar 15, 2039
LLY4217068
Eli Lilly and Company 3.7% 01-MAR-2045Yield to maturity
6.14%
Maturity date
Mar 1, 2045
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
6.06%
Maturity date
Feb 27, 2063
See all LILY34 bonds
Curated watchlists where LILY34 is featured.